Health Care: Drugs

ACADIA Pharmaceuticals Inc (ACAD: NASDAQ)

$20.913 0.083 | 0.4%
07/25/14 - 09:56 AM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 1.14M 4.91M 2.07M 42.14M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 1.14M 4.91M 2.07M 42.14M
Selling, General, and Administrative Expenses 12.72M 7.00M 7.61M 6.46M
Research & Development 26.72M 18.79M 17.31M 20.58M
Operating Income before D & A (EBITDA) -38.30M -20.89M -22.85M 15.09M
Depreciation & Amortization 1.61M -24.00K 390.00K 607.00K
Interest Income 349.00K 37.00K 87.00K 45.00K
Other Income - Net 0.00 0.00 0.00 0.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -39.56M -20.82M -23.16M 14.53M
Interest Expense 0.00 0.00 0.00 0.00
Pre-Tax Income -39.56M -20.82M -23.16M 14.53M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -37.95M -20.85M -22.76M 15.14M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -37.95M -20.85M -22.76M 15.14M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -37.95M -20.85M -22.76M 15.14M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-37.95M -20.85M -22.76M 15.14M
Preferred Dividends
Net Income Available To Common -37.95M -20.85M -22.76M 15.14M
Basic EPS from Continuing Ops. -0.44 -0.38 -0.44 0.39
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.44 -0.38 -0.44 0.39
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.44 -0.38 -0.44 0.39
Basic Normalized Net Income/Share -0.44 -0.38 -0.44 0.39
EPS fr Continuing Ops. -0.44 -0.38 -0.44 0.39
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.44 -0.38 -0.44 0.39
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.44 -0.38 -0.44 0.39
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.44 -0.38 -0.44 0.39
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ACAD

Latest ACAD Headlines from TheStreet

More Financial News for ACAD

Press Releases for ACAD

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter